Kiira Kalke

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Herpes Simplex Virus

Hyaluronic Acid

Magnetic Resonance

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Jussi Palomäki, Kiira Kalke, Julius Orpana, Liisa M Lund, Fanny Frejborg, Henrik Paavilainen, Hannu Järveläinen, Veijo Hukkanen
Attenuated Replication-Competent Herpes Simplex Virus Expressing an ECM-Modifying Transgene Hyaluronan Synthase 2 of Naked Mole Rat in Oncolytic Gene Therapy. Microorganisms 11 (11) (2023)
Kiira Kalke, Liisa M Lund, Marie C Nyman, Alesia A Levanova, Arto Urtti, Minna M Poranen, Veijo Hukkanen, Henrik Paavilainen
Swarms of chemically modified antiviral siRNA targeting herpes simplex virus infection in human corneal epithelial cells. PLoS pathogens 18 (7) (2022)
Alesia A Levanova, Mirka Lampi, Kiira Kalke, Veijo Hukkanen, Alejandro Reyes Muñoz, Katri Eskelin
Native RNA Purification Method for Small RNA Molecules Based on Asymmetrical Flow Field-Flow Fractionation. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Kiira Kalke, Julius Orpana, Tuomas Lasanen, Olaya Esparta, Liisa M Lund, Fanny Frejborg, Tytti Vuorinen, Henrik Paavilainen, Veijo Hukkanen
The In Vitro Replication, Spread, and Oncolytic Potential of Finnish Circulating Strains of Herpes Simplex Virus Type 1. Viruses 14 (6) (2022)
Kiira Kalke, Jenni Lehtinen, Jelena Gnjatovic, Liisa M Lund, Marie C Nyman, Henrik Paavilainen, Julius Orpana, Tuomas Lasanen, Fanny Frejborg, Alesia A Levanova, Tytti Vuorinen, Alejandro Reyes Muñoz, Veijo Hukkanen
Herpes Simplex Virus Type 1 Clinical Isolates Respond to UL29-Targeted siRNA Swarm Treatment Independent of Their Acyclovir Sensitivity. Viruses 12 (12) (2020)